9 Atopic Dermatitis Clinical Trials in St. Petersburg, FL (2026)

Q: How do I join a clinical trial in St. Petersburg?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you.

Recruiting Atopic Dermatitis Studies in St. Petersburg

NCT05579366Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that ha...

St. Petersburg, FLPHASE1884 participantsGenmab

View Study Details

NCT06256588Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

The goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with Head and Neck Squamous Cell Carcinoma (HNSCC)...

St. Petersburg, FLPHASE3864 participantsGlaxoSmithKline

View Study Details

NCT06525220Recruiting

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

This is a Phase 3 randomized, open-label study to evaluate the efficacy and safety of petosemtamab plus pembrolizumab vs pembrolizumab in first-line treatment of recurrent or metastatic PD-L1+ head an...

St. Petersburg, FLPHASE3700 participantsMerus N.V.

View Study Details

NCT07129993Recruiting

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

This is a global, multicenter, randomized, open-label, Phase 2/3 study of Dato-DXd plus carboplatin or cisplatin versus gemcitabine plus carboplatin or cisplatin in participants with la/mUC who progre...

St. Petersburg, FLPHASE2630 participantsDaiichi Sankyo

View Study Details

NCT07690371Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

This is an interventional, randomized, parallel group, treatment, Phase 3, double blind study to assess the effect of Rezpegaldesleukin in participants 12 years of age or older with moderate to severe...

St. Petersburg, FLPHASE3510 participantsNektar Therapeutics

View Study Details

NCT07765888Recruiting

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

The purpose of this study is to find out how well tilrekimig works, how safe it is, and how it affects the body when used together with medicated creams or ointments in adults and adolescents with mod...

St. Petersburg, FLPHASE3375 participantsPfizer

View Study Details

NCT06947993Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD)....

St. Petersburg, FLPHASE2224 participantsNovartis Pharmaceuticals

View Study Details

NCT07387367Recruiting

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

This randomized, open-label, parallel group, two-arm, multi-center assessment will compare IV BCV with IV CDV in adult and pediatric allogeneic HCT recipients with AdV viremia. A virologic response-dr...

St. Petersburg, FLPHASE3180 participantsSymBio Pharmaceuticals

View Study Details

NCT05277168Recruiting

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to determine maximum tolerated dose (MTD) and/or...

St. Petersburg, FLPHASE183 participantsJiangsu HengRui Medicine Co., Ltd.

View Study Details

About Atopic Dermatitis Clinical Trials in St. Petersburg

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 9 atopic dermatitis clinical trials recruiting participants in St. Petersburg, FL. These studies are seeking a combined 4,450 participants. Research is being sponsored by Genmab, GlaxoSmithKline, Merus N.V. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in St. Petersburg — FAQ

Are there atopic dermatitis clinical trials in St. Petersburg?

Yes, there are 9 atopic dermatitis clinical trials currently recruiting in St. Petersburg, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St. Petersburg?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you about next steps.

Are clinical trials in St. Petersburg free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St. Petersburg studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 9 active trials in St. Petersburg are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated September 5, 2026 from ClinicalTrials.gov